RESUMEN
We applied an acute stress model to zebra fish in order to measure the changes in the metabolome due to biological stress. This was done by submitting the fish to fifteen minutes of acute confinement (netting) stress, and then five minutes for the open field and light/dark field tests. A polar extract of the zebra fish was then subjected to (1)H nuclear magnetic spectroscopy. Multivariate data analysis of the spectra showed a clear separation associated to a wide range of metabolites between zebra fish that were submitted to open field and light/dark field tests. Alanine, taurine, adenosine, creatine, lactate, and histidine were high in zebra fish to which the light/dark field test was applied, regardless of stress, while acetate and isoleucine/lipids appeared to be higher in zebra fish exposed to the open field test. These results show that any change in the environment, even for a small period of time, has a noticeable physiological impact. This research provides an insight of how different mechanisms are activated under different environments to maintain the homeostasis of the body. It should also contribute to establish zebra fish as a model for metabolomics studies.
Asunto(s)
Metaboloma , Estrés Fisiológico , Estrés Psicológico , Pez Cebra , Animales , Femenino , Espectroscopía de Resonancia Magnética/métodos , Masculino , Metabolómica , Análisis Multivariante , Restricción FísicaRESUMEN
(-)-Carvone is a monoterpene ketone found in spearmint (Mentha spicata var. crispa) essential oil that is widely used as an odor and flavor additive. An intestinal antispasmodic effect was recently reported for (-)-carvone, and it has been shown to be more potent than its (+)-antipode. The mechanism of (-)-carvone action in the intestines has not been investigated. To gain a better understanding of the (-)-carvone antispasmodic effect, we investigated its pharmacological effects in the guinea pig ileum. Terminal portions of the ileum were mounted for isotonic contraction recordings. The effect of (-)-carvone was compared with that of the classical calcium channel blocker (CCB) verapamil. In isolated ileal smooth muscle, (-)-carvone did not produce direct contractile or relaxation responses and did not modify electrically elicited contractions or low K(+)-evoked contractions. The submaximal contractions induced by histamine (p<0.001), BaCl2 (p<0.05), and carbachol (p<0.01) were significantly reduced by (-)-carvone. The contractile response elicited by high concentrations of carbachol was reduced but not abolished by (-)-carvone. No additive action was detected with co-incubation of (-)-carvone and verapamil on carbachol-induced contraction. (-)-Carvone reduced the contraction induced by high K(+) and was almost 100 times more potent than verapamil. Thus, (-)-carvone showed a typical and potent CCB-like action. Many effects described for both (-)-carvone and spearmint oil can be explained as a CCB-like mode of action.
Asunto(s)
Canales de Calcio/efectos de los fármacos , Íleon/efectos de los fármacos , Monoterpenos/farmacología , Músculo Liso/efectos de los fármacos , Parasimpatolíticos/farmacología , Canales de Potasio/efectos de los fármacos , Animales , Compuestos de Bario , Bloqueadores de los Canales de Calcio/análisis , Carbacol , Cloruros , Monoterpenos Ciclohexánicos , Evaluación Preclínica de Medicamentos , Femenino , Cobayas , Histamina , Técnicas In Vitro , Masculino , Mentha spicata/química , Cloruro de Potasio , VerapamiloRESUMEN
The antispasmodic effect of 4'-methylepigallocatechin (MEC), which was isolated from Maytenus rigida Mart (Celestraceae), was investigated in vitro in guinea pig intestinal segments. In the isolated ileum, MEC (1 nM-100 µM) did not modify the ileal spontaneous tonus or the electrically elicited contractions. MEC (8 µM) significantly (p<0.01) reduced the submaximal contractions induced by histamine (2 µM), carbachol (100 µM) and BaCl2 (0.03 M). An additive relaxing action (p<0.001) was observed by co-incubation of verapamil (10 nM) and MEC (8 µM). Although MEC (1 nM-100 µM) did not modify the contractions elicited by 60 mM KCl, it significantly reduced the CaCl2 contractile response without changing the EC50 (effective concentration of CaCl2 causing 50% of maximum response). In brief, these results show that MEC has a potent ileal spasmolytic effect and blocks spasms induced by specific and nonspecific stimuli. Importantly, the spasmolytic effects were attained at low concentrations and might be related to the symptomatic relief of abdominal pain that is obtained from the use of the M. rigida stem bark.
Asunto(s)
Catequina/análogos & derivados , Íleon/efectos de los fármacos , Maytenus/química , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Parasimpatolíticos/farmacología , Extractos Vegetales/farmacología , Animales , Compuestos de Bario/farmacología , Cloruro de Calcio/farmacología , Carbacol/farmacología , Catequina/aislamiento & purificación , Catequina/farmacología , Cloruros/farmacología , Cobayas , Histamina/farmacología , Parasimpatolíticos/aislamiento & purificación , Extractos Vegetales/química , Cloruro de Potasio/farmacología , Verapamilo/farmacologíaRESUMEN
CONTEXT: Erythrina velutina (EV) Willd (Fabaceae-Faboideae) is a medicinal tree that is commonly used in Brazil for the treatment of several central nervous system disorders. OBJECTIVE: The anticholinesterase activity of EV is described in this work. METHODS: Concentration-response curves (0-1.6 mg/mL) for EV leaf aqueous extract (AE) and alkaloid-rich extracts (AKEs) were performed in vitro. Cholinesterase inhibition was examined in mouse brains, as the cholinesterase source, and in pure acetylcholinesterase (AChE) or butyrylcholinesterase (BuChE). Mice were treated with AE or AKE (100, 200, and 400 mg/kg, p.o.) and their brains were used for the measurement of cholinesterase activity (CA) ex vivo. RESULTS: CA was inhibited by AE (IC(50) = 0.57 [0.43-0.75] mg/mL) and AKE (IC(50) = 0.52 [0.39-0.70] mg/mL) in brain homogenates in a concentration-dependent manner. The ex vivo experiments indicated that AE (400 mg/kg, p < 0.05, 32.2 ± 3.9% of inhibition) and AKE (all doses: p < 0.05-p < 0.001, 29.6 ± 3.2% as the maximum inhibition) significantly inhibited CA in the central nervous system after oral administration. AE and AKE inhibited AChE and BuChE activities in a concentration-dependent manner (AE: IC(50AChE) = 0.56 [0.38-0.81] mg/mL, IC(50BuChE) = 2.95 [1.51-5.76] mg/mL, AKE: IC(50AChE) = 0.87 [0.60-12.5] mg/mL, IC(50BuChE) = 2.67 [0.87-8.11] mg/mL). DISCUSSION AND CONCLUSIONS: These data indicated that AE and AKE crossed the blood-brain barrier to inhibit CA in the brain. AE and AKE also exhibited a dual inhibitory action on acetyl- and BuChE.